-       Report 
- August 2023
-  17 Pages 
- United States 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- United Kingdom 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- Spain 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- South Korea 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- Russia 
   From       €2665EUR$2,995USD£2,346GBP 
           -       Report 
- August 2023
-  17 Pages 
- Mexico 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- Japan 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- Italy 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- France 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- China 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- August 2023
-  17 Pages 
- Brazil 
   From       €2665EUR$2,995USD£2,346GBP 
          -       Report 
- January 2025
-  132 Pages 
- Global 
   From       €845EUR$950USD£744GBP 
          -       Report 
- January 2025
-  132 Pages 
- Global 
   From       €845EUR$950USD£744GBP 
          -       Report 
- November 2021
-  844 Pages 
- Global 
   From       €4449EUR$5,000USD£3,917GBP 
              -       Book 
- April 2019
- North America 
             -       Book 
- September 2018
- North America 
              
      The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression,    addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less   Read more